Literature DB >> 16505965

Motor development and neuropsychological patterns in persons with Down syndrome.

Stefano Vicari1.   

Abstract

Neuropsychological research has permitted defining specific cognitive profiles among individuals with mental retardation (MR) of different etiology. Namely, the cognitive profile of people with Down syndrome (DS) is often reported to be characterized by a deficit in language abilities that usually exceed impairments in visual-spatial capacities. However, recent studies have demonstrated a more complex neuropsychological profile in this population, with atypical development in the cognitive and in the linguistic domain. This paper is dedicated to reviewing literature regarding motor, linguistic and cognitive abilities in DS. Our aim is to present evidences supporting the hypothesis that individuals with these syndrome exhibit a peculiar motor development and neuropsychological profile with some abilities more preserved and others more impaired. This finding may have theoretical and practical implications. In fact, a better definition of the cognitive pattern in DS may contribute to understand the nature of MR in general and, also, it may suggests individualized rehabilitation treatment protocols.

Entities:  

Mesh:

Year:  2006        PMID: 16505965     DOI: 10.1007/s10519-006-9057-8

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  45 in total

1.  Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome.

Authors:  Jisook Moon; May Chen; Shruti U Gandhy; Myla Strawderman; David A Levitsky; Kenneth N Maclean; Barbara J Strupp
Journal:  Behav Neurosci       Date:  2010-06       Impact factor: 1.912

2.  Motor training at 3 months affects object exploration 12 months later.

Authors:  Klaus Libertus; Amy S Joh; Amy Work Needham
Journal:  Dev Sci       Date:  2015-12-21

3.  Study on the social adaptation of Chinese children with down syndrome.

Authors:  Yan-Xia Wang; Shan-Shan Mao; Chun-Hong Xie; Yu-Feng Qin; Zhi-Wei Zhu; Jian-Ying Zhan; Jie Shao; Rong Li; Zheng-Yan Zhao
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

4.  Adaptation of the Arizona Cognitive Task Battery for use with the Ts65Dn mouse model (Mus musculus) of Down syndrome.

Authors:  Michael R Hunsaker; Genevieve K Smith; Raymond P Kesner
Journal:  J Comp Psychol       Date:  2017-03-23       Impact factor: 2.231

5.  Alterations in the Serotonin and Dopamine Pathways by Cystathionine Beta Synthase Overexpression in Murine Brain.

Authors:  J London; F K Ndiaye; L C Bui; B Souchet; F Daubigney; C Magnan; S Luquet; J Dairou; N Janel; C Rouch
Journal:  Mol Neurobiol       Date:  2018-09-20       Impact factor: 5.590

6.  Impaired locomotor learning and altered cerebellar synaptic plasticity in pep-19/PCP4-null mice.

Authors:  Peng Wei; Jay A Blundon; Yongqi Rong; Stanislav S Zakharenko; James I Morgan
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

Review 7.  Speech impairment in Down syndrome: a review.

Authors:  Ray D Kent; Houri K Vorperian
Journal:  J Speech Lang Hear Res       Date:  2012-12-28       Impact factor: 2.297

8.  Mothers and Fathers at Play with their Children with Down Syndrome: Influence on Child Exploratory and Symbolic Activity.

Authors:  Simona de Falco; Gianluca Esposito; Paola Venuti; Marc H Bornstein
Journal:  J Appl Res Intellect Disabil       Date:  2010-04-14

9.  Relations between Everyday Executive Functioning and Language in Youth with Down Syndrome and Youth with Autism Spectrum Disorder.

Authors:  Manisha Udhnani; Megan Perez; Liv S Clasen; Elizabeth Adeyemi; Nancy Raitano Lee
Journal:  Dev Neuropsychol       Date:  2020-02-16       Impact factor: 2.253

10.  Abnormal expression of synaptic proteins and neurotrophin-3 in the Down syndrome mouse model Ts65Dn.

Authors:  G Pollonini; V Gao; A Rabe; S Palminiello; G Albertini; C M Alberini
Journal:  Neuroscience       Date:  2008-07-25       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.